Author: Imbio LLC Source: Company Data (
click here to go to the source)
Imbio announces $1.5 million financing
Funds PRM Lung, CT Imaging Biomarker for COPD
Minneapolis, MN. — Imbio, LLC, a medical imaging software company, has closed on $1.5 million
in Series A financing. Existing investor Invenshure, LLC, led the round with additional funding from
several angel investors. The proceeds will support the commercialization of Imbio's proprietary
Parametric Response Mapping (PRM) technology used to detect, characterize and quantify
abnormal tissue in computed tomography (CT), magnetic resonance imaging (MRI) and positron
emission tomography (PET) images.
"We appreciate the continued support of our investors as we move closer to launching the first
application of our PRM technology, PRM LUNG," said Troy Kopischke, President and Chief
Operating Officer of Imbio. "PRM LUNG is designed to significantly improve the diagnostic power
of CT scans in chronic obstructive pulmonary disease (COPD), a progressive condition that is the
third leading cause of death in the U.S."
Danny Cunagin, co-founder of Invenshure, commented, "We are pleased to support this
breakthrough technology. PRM LUNG has the potential to be the first imaging software to
distinguish between the sub-types of COPD, helping physicians personalize treatment for patients."
About Imbio, LLC
Imbio, LLC, is a medical imaging company founded to commercialize quantitative imaging
biomarkers developed by leading universities and research institutions. Imaging biomarkers are
key drivers of personalized medicine, which is rapidly evolving due to "big data" availability in cloud
databases. Imbio is developing and licensing several imaging biomarkers that will be added to the
company's growing imaging/processing cloud platform. For more information, visit www.imbio.com.
About Invenshure, LLC
Formed in 2011 by seasoned serial entrepreneurs Danny Cunagin and Troy Kopischke, Invenshure
combines a technology incubator (Invenshure, LLC) and a fund (Invenshure Fund I) to launch and
grow technology-based companies. The principals at Invenshure search industry and universities,
commercializing novel medical informatics, therapeutic and platform technologies in the rapidly
evolving healthcare marketplace. Find out more at www.invenshure.com.
